Results 171 to 180 of about 201,913 (257)

Model‐based clinical pharmacology profiling of subcutaneous nivolumab in renal cell carcinoma: Bridging to alternative dosing regimens and indications

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
A novel model‐informed drug development (MIDD) approach was employed to derive the coprimary endpoints (time‐averaged serum concentration over 28 days [Cavgd28] and minimum serum concentration at steady state [Cminss]) of the phase III CheckMate 67T study (NCT04810078).
Yue Zhao   +5 more
wiley   +1 more source

How Institutional Environments Shape the ESG–Growth Relation: Evidence From Europe

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT As global financial markets increasingly integrate non‐financial criteria, companies are reinforcing the strategic role of sustainability and its impact on market value, although this cannot overlook how different institutional structures shape investor perceptions.
Laura Bango‐López   +3 more
wiley   +1 more source

The Price of Circularity: Exploring the Determinants of Consumer Willingness to Pay

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT The transition towards a circular economy (CE) requires not only technological and organisational innovation but also consumer engagement in adopting circular products. A key driver of this process is consumers' stated willingness to pay (WTP) a premium, which remains constrained by psychological, perceptual and contextual barriers.
Valerio Muto   +3 more
wiley   +1 more source

The Synergy of Green HRM and a Proactive Environmental Strategy in Cultivating Environmental and Financial Performance Through Green Innovation

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This study examines how green human resource management (HRM) contributes to environmental and financial performance via green innovation. We develop and test a moderated mediation model in which green product and green process innovation act as parallel mediating mechanisms, while proactive environmental strategy moderates their effectiveness.
Ana Labella‐Fernández   +2 more
wiley   +1 more source

Strategic Shift to Sustainable Competitive Advantage With Biodiversity Purpose: An Adaptive Capacity Approach

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT Drawing on adaptive capacity research, this study provides an assessment of the sustainable competitive advantage of a strategic shift with social purpose, leveraging green revenue to drive biodiversity outcomes. The study employs panel regression analysis on a distinctive dataset for the period 2015–2024, focusing on S&P 1500 firms. Using the
Post Raj Pokharel   +1 more
wiley   +1 more source

Correction: A brain-enriched circRNA blood biomarker can predict response to SSRI antidepressants. [PDF]

open access: yesMol Psychiatry
Papageorgiou G   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy